Trial Outcomes & Findings for RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief (NCT NCT02046382)

NCT ID: NCT02046382

Last Updated: 2018-08-16

Results Overview

Total oxycodone (mg) for breakthrough pain during inpatient stay

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

132 participants

Primary outcome timeframe

approximately 2 - 7 days

Results posted on

2018-08-16

Participant Flow

Participant milestones

Participant milestones
Measure
IV Acetaminophen
Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. IV Acetaminophen: 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Normal Saline
Subjects will receive a 100mL dose of saline every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. Placebo: 100 mL of Normal Saline every 8 hours for 48 hours. The first does will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Overall Study
STARTED
65
67
Overall Study
COMPLETED
57
47
Overall Study
NOT COMPLETED
8
20

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
IV Acetaminophen
n=57 Participants
Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. IV Acetaminophen: 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Normal Saline
n=47 Participants
Subjects will receive a 100mL dose of saline every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. Placebo: 100 mL of Normal Saline every 8 hours for 48 hours. The first does will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Total
n=104 Participants
Total of all reporting groups
Age, Continuous
29.6 years
STANDARD_DEVIATION 6.0 • n=5 Participants
29.6 years
STANDARD_DEVIATION 6.1 • n=7 Participants
29.6 years
STANDARD_DEVIATION 6.0 • n=5 Participants
Sex: Female, Male
Female
57 Participants
n=5 Participants
47 Participants
n=7 Participants
104 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · White
33 Participants
n=5 Participants
27 Participants
n=7 Participants
60 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · African American
21 Participants
n=5 Participants
19 Participants
n=7 Participants
40 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Multiracial
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Other
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
57 Participants
n=5 Participants
47 Participants
n=7 Participants
104 Participants
n=5 Participants

PRIMARY outcome

Timeframe: approximately 2 - 7 days

Total oxycodone (mg) for breakthrough pain during inpatient stay

Outcome measures

Outcome measures
Measure
IV Acetaminophen
n=57 Participants
Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. IV Acetaminophen: 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Normal Saline
n=47 Participants
Subjects will receive a 100mL dose of saline every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. Placebo: 100 mL of Normal Saline every 8 hours for 48 hours. The first does will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Total Oxycodone (mg)
47.0 mg
Standard Deviation 39.1
65.0 mg
Standard Deviation 46.2

SECONDARY outcome

Timeframe: 2-7 days

Only outcome for nausea/emesis is reported.

Outcome measures

Outcome measures
Measure
IV Acetaminophen
n=57 Participants
Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. IV Acetaminophen: 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Normal Saline
n=47 Participants
Subjects will receive a 100mL dose of saline every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. Placebo: 100 mL of Normal Saline every 8 hours for 48 hours. The first does will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Number of Participants With Narcotic Associated Side Effects
17 Participants
9 Participants

SECONDARY outcome

Timeframe: 2-7 days

Length of hospital stay (admission to discharge) will be collected.

Outcome measures

Outcome measures
Measure
IV Acetaminophen
n=57 Participants
Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. IV Acetaminophen: 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Normal Saline
n=47 Participants
Subjects will receive a 100mL dose of saline every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. Placebo: 100 mL of Normal Saline every 8 hours for 48 hours. The first does will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Length of Stay
78 hours
Interval 74.0 to 95.0
78 hours
Interval 75.0 to 98.0

OTHER_PRE_SPECIFIED outcome

Timeframe: 2-7 days

Patients will have access to ibuprofen for mild to moderate pain. The amount consumed during inpatient stay will be collected.

Outcome measures

Outcome measures
Measure
IV Acetaminophen
n=57 Participants
Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. IV Acetaminophen: 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Normal Saline
n=47 Participants
Subjects will receive a 100mL dose of saline every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given. Placebo: 100 mL of Normal Saline every 8 hours for 48 hours. The first does will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
Total Amount of Ibuprofen During Inpatient Stay
4786 mg
Standard Deviation 2333
5260 mg
Standard Deviation 1915

Adverse Events

IV Acetaminophen

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Normal Saline

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Clinical Research Specialist

TriHealth

Phone: 513-862-2341

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place